These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3576164)

  • 21. [Clinical aspects and differential diagnosis of primary acral circulatory disorders].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1983 Mar; 38(6):175-8. PubMed ID: 6868706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vascular reactivity to cold. Study in normal subjects and in vascular acrosyndromes].
    Schmidt C; Schmitt J; Demange G
    J Mal Vasc; 1984; 9(1):29-33. PubMed ID: 6707532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of thermography in the clinical evaluation of microcirculation].
    Iakhontova OI; Rutgaĭzer IaM; Somova EP
    Ter Arkh; 1987; 59(4):97-100. PubMed ID: 3590013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of a computer-assisted thermoelectric Peltier cold test procedure with integrated photoplethysmography unit for noninvasive evaluation of acral skin circulation].
    Klyscz T; Hahn M; Beck W; Blazek V; Rassner G; Jünger M
    Biomed Tech (Berl); 1997 Sep; 42(9):234-9. PubMed ID: 9410153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Raynaud's phenomenon. Practical considerations on the forms secondary to immunomediated systemic diseases].
    Marcolongo R; Corà F; Laveder F; Cavallo M; Busato A; Rigoli AM
    Minerva Med; 1997; 88(7-8):307-10. PubMed ID: 9304074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of local finger cooling on laser Doppler flux and nailfold capillary blood flow velocity in normal subjects and in patients with Raynaud's phenomenon.
    Lütolf O; Chen D; Zehnder T; Mahler F
    Microvasc Res; 1993 Nov; 46(3):374-82. PubMed ID: 8121320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New ways of studying the cutaneous microcirculation in clinical medicine (author's transl)].
    Bollinger A; Jäger K
    Arzneimittelforschung; 1981; 31(11a):2015-9. PubMed ID: 7199291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
    Pistorius MA; Planchon B; de Faucal P
    Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders.
    Murray AK; Moore TL; Manning JB; Taylor C; Griffiths CE; Herrick AL
    Arthritis Rheum; 2009 Aug; 61(8):1103-11. PubMed ID: 19644893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
    Vayssairat M; Mathieu JF; Housset E
    J Mal Vasc; 1984; 9(1):7-10. PubMed ID: 6707534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Capillaroscopy in vibration disease].
    Vayssairat M; Patri B; Guilmot JL; Housset E; Dubrisay J
    Nouv Presse Med; 1982 Oct; 11(42):3111-5. PubMed ID: 7177825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
    Jünger M; Steins A; Hahn M; Häfner HM
    Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic characteristics of laser-Doppler flux in normal individuals and patients with Raynaud's phenomenon before and after treatment with nifedipine under different thermal conditions.
    Popivanov D; Mineva A; Bendayan P; Leger P; Boccalon H; Möller KO
    Technol Health Care; 1999; 7(2-3):193-203. PubMed ID: 10463308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reaction of capillary blood cell velocity in nailfold capillaries to L-carnitine in patients with vasospastic disease.
    Gasser P; Martina B; Dubler B
    Drugs Exp Clin Res; 1997; 23(1):39-43. PubMed ID: 9093821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooling patterns in Raynaud's phenomenon and allied peripheral vascular disorders.
    James PB
    Br J Surg; 1968 Nov; 55(11):860. PubMed ID: 5686991
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon.
    Neuhauser B; Perkmann R; Klingler PJ; Giacomuzzi S; Kofler A; Fraedrich G
    Am Surg; 2001 Nov; 67(11):1096-7. PubMed ID: 11730228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.